Tag: oral immunotherapy (OIT)
IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...
IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...
Latitude Food Allergy Care: Transforming Lives with Oral Immunotherapy (OIT)
An interview with Kimberley Yates, Founder and CEO, Latitude Food Allergy Care
You’ve read about the studies here for years and maybe even had a...
Study of Boiled Peanuts Show Promise for Treatment of Peanut Allergy
OIT with boiled followed by roasted peanuts appears effective with a favorable safety profile.
Study Determines What Patients Prefer for Maintenance After Completing OIT with...
Patients chose from continuing with Palforzia or switching to a common food.
Treating Multiple Allergens at the Same Time with OIT Saves Time...
A trade-off to consider with multi-allergen oral immunotherapy.
Positive Results from Phase 3 Study of PALFORZIA® in Peanut-Allergic Children...
73.5% of patients treated met the primary outcome at 12 months compared with 6.3% of patients in the placebo arm.
Most Adults Achieve Food Allergy Desensitization with Oral Immunotherapy
But rates were lower than those for children and adolescents.
Experimental Cat Allergy Shots Provide Longer-Lasting Relief
This approach might also be effective for other types of allergies, including food allergies.
ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy
Sublingual Immunotherapy is administered via medications placed under the tongue.
Q&A: Egg Allergy
Answers to common questions regarding symptoms, triggers, vaccine safety, and more.
